Kevin B. Stansberry

I. Personal Data

Kevin B. Stansberry

e-mail: [personal]  kevin@stansberry.com

internet:  [personal]  www.kevin.stansberry.org 

Telephone and fax:  [provided on request as appropriate]

 

II. Skills Summary

  • Experienced in designing, performing, and communicating clinical research:  12 years experience in an academic research institute, progressing to Director level.  2 years of medical writing experience. 
  • Expert in clinical research design, analysis (including advanced statistical and graphical analyses), and reporting in all formats:
    • Protocol and grant writing:  over 30 grant applications, including investigator-initiated clinical trials, NIH grant applications, other private and public funding sources
    • Oversight and training of clinical research staff in all components of clinical trial execution
    • Statistical analysis of all components of clinical trials and basic science experiments
    • Manuscript writing, editing and submission:  over 20 papers published in various journals
    • Abstract writing and submission:  prepared over 50 abstracts, 40 were presented
    • Poster and slide kit writing and preparation:  prepared over 30 posters, over 50 slide kits for talks, collaborated on many more
    • Presentation skills:  oral and poster presentations at international, national, regional, and local meetings
  • Gaining expertise in regulatory writing, including:  CSR, IB, Clinical Overview, Clinical Summary
  • Advanced computer skills including all MS operating systems and Office suites, PC hardware, web content creation and website creation and maintenance

 

III. Education

Undergraduate:  Bachelor of Science in Industrial/Organizational Psychology

Old Dominion University,  Norfolk, VA

Earned December, 1990.   Psi Chi: Academic Honor Society

 

Graduate:  Master of Science in Biomedical Science:  Systems Biology and Biophysics Track

Eastern Virginia Medical School, Norfolk, VA

Earned August 2004

Thesis title:  The Role of the Neuronal Isoform of Nitric Oxide Synthase (nNOS) in the Dermal Neurogenic Response to Graded Heating

 

IV. Experience

 

9/05 to present   Medical Communication Scientist, AstraZeneca Pharmaceuticals LP, Wilmington, DE.  Writing regulatory materials including Investigator Brochures, Clinical Study Reports, and Summary Documents (CTD modules 2.5, 2.7, and 5). 

 

10/04 to 8/05      Senior Clinical Writer, ECRI, Plymouth Meeting, PA.  ECRI (ecri.org) is a nonprofit health services research agency, a Collaborating Center of the World Health Organization (WHO); and is designated as an Evidence-based Practice Center (EPC) by the U.S. Agency for Healthcare Research and Quality (AHRQ).  While there, I wrote healthcare technology assessments and forecasts of emerging healthcare technologies, and collaborated in the writing of systematic reviews.

 

3/04 to 10/04     Medical Writer, freelance/contractual.  Writing and editing original articles, reviews, abstracts, posters, and slide sets for medical communications clients. 

 

8/01 to 1/04       Director, Neurovascular Laboratory, Diabetes Institutes, Clinical Research, Eastern Virginia Medical School, Norfolk, VA.  Direction and supervision of Neurovascular laboratory that investigates skin perfusion and neuronal function in people with diabetes and other neurologic disorders.

 

7/98 to 8/01        Research Associate II, Diabetes Institutes, Clinical Research, Eastern Virginia Medical School, Norfolk, VA.  Planning, grant writing, supervision, analysis, report and manuscript preparation of research into abnormalities of neurologic function in people with diabetes and other neurologic disorders.

 

7/94 to 7/98        Research Assistant II, Diabetes Institutes, Clinical Research, Eastern Virginia Medical School, Norfolk, VA.  Planning, execution, report and manuscript preparation of research into abnormalities of neurologic function in people with diabetes.

 

1/91 to 7/94        Research Assistant I, Diabetes Institutes, Clinical Research, Eastern Virginia Medical School, Norfolk, VA.  Execution, report and manuscript preparation of research into abnormalities of neurologic function in people with diabetes.

 

9/90 to 1/91        Research Assistant, Old Dominion University.  Assisting with data correction, analysis, and interpretation for a study of cognitive function in diabetes.

 

10/90-2/91          Research Assistant, volunteer researcher at Old Dominion University animal research laboratory.  Work involved care of streptozotocin-induced diabetic Wistar rats and extensive work with the Morris Water Maze.

 

V. Awards and Professional Memberships

5-5-1995       American Diabetes Association, Virginia Affiliate, Young Investigator.  Nominated for work in diabetic neuropathy and control of peripheral blood flow.

 

1993-2003    American Diabetes Association, Professional Member

 

6-2004 to present:  American Medical Writers Association, Member

 

 

VI. Invited Lectureships

2-17-91         Old Dominion University Psychological Research Seminars, Series I:  Effects of memory set size on reaction times in an item-recognition task. Old Dominion University.

 

6-25-93         Old Dominion University / National Science Foundation Educational Series:  Clinical research and technology application in diabetes research.  Eastern Virginal Medical School and Old Dominion University.

 

4-25-94                 Eastern Virginia Medical School Microsurgical Research Seminar Series:  Cutaneous Sensory Evaluation.  Eastern Virginal Medical School.

 

7-24-97                 Diabetes Seminar, Stansberry, K. B., Peppard, H. R.  C-Fiber Nociceptive Neurons and Poor Skin Blood Flow:  Which is the Horse and Which is the Cart?  Eastern Virginia Medical School.

 

7-24-98                 Diabetes Seminar, Freund, B. M., Stansberry, K. B. Statistics for the rest of us.  Eastern Virginia Medical School.

 

10-18-2000   Diabetes Seminar, Stansberry, K. B. and Tiriveedi, M.  Aging, neuropathy and risk of falling:  An NIH-sponsored study of the elderly.  Eastern Virginia Medical School.

 

1-17-2001     Neuroscience Group Seminar:  Neurogenic vasodilation:  Mechanisms of interaction of skin neurons and microcirculation.  Eastern Virginia Medical School.

 

5-17-2001         Diabetes Seminar, Stansberry, K. B.  Looking in on Outlook: An introductory Seminar.  Eastern Virginia Medical School.

 

2-20-2002     Diabetes Seminar, Stansberry, K. B.   Excel™-ing in Research and Clinical Practice:  Using Microsoft Excel To Get Your Data In Order and To Present it To Other People.  Eastern Virginia Medical School, 2-part training series.

 

VII. Articles in Scientific Journals, Invited or Reviews

1.      Vinik, A. I., Holland, M. T., LeBeau, J. M., Liuzzi, F. J., Stansberry, K. B., Colen, L. B. (1992)  Diabetic neuropathies.  Diabetes Care, 15:1926-1975.  Pubmed Link

 

2.      Vinik AI, Erbas T, and Stansberry KB. (1999)  Gastrointestinal, genitourinary, and neurovascular disturbances in diabetes.  Diabetes Reviews, 7:358-378. 

 

3.       Vinik, A. I., Park, T. S., Stansberry, K. B., Pittenger, G. L. (2000) Review. Diabetic neuropathies.  Diabetologia 43:957-973.  Pubmed Link

 

4.       Vinik, A. I., Erbas, T., and Stansberry, K. B. (2000) Gastrointestinal, genitourinary, and neurovascular disturbances in diabetes. Annual Review of Diabetes (originally published in Diabetes Reviews 1999) 1:346-366.

 

5.       Vinik, A. I., Erbas, T., Park, T. S., Stansberry, K. B., Scanelli, J. A., Pittenger, G. L. (2001)  Dermal neurovascular dysfunction in type 2 diabetes.  Diabetes Care 24:1468-1475.  Pubmed Link  Full Text (pdf)

 

6.      Vinik, A. I., Erbas, T., Park, T. S., Pierce, K. K., and Stansberry, K. B. (2001)  Methods for evaluation of peripheral neurovascular dysfunction.  Diabetes Technology and Therapeutics 3:29-50.  Pubmed Link 

7.      Vinik A.I., Erbas T., Stansberry K.B., Pittenger G.L. (2001)  Small fiber neuropathy and neurovascular disturbances in diabetes mellitus.  Experimental and Clinical Endocrinology & Diabetes 109 Suppl 2:S451-73.  Pubmed Link

VIII. Articles in Scientific Journals, Peer Reviewed

1.             Vinik, A. I., Suwanwalaikorn, S., Stansberry, K. B., Holland, M. T., McNitt, P. M., Colen, L. E. (1995)  Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle & Nerve 18:574-584.  Pubmed Link

2.             Vinik, A. I., Leichter, S. B., Pittenger, G. L., Stansberry, K. B., Holland, M. T., Powers, A. C., Suwanwalaikorn, S. (1995)  Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy. Diabetes Care 18(9): 1225-1232.  Pubmed Link

3.             Vinik, A. I., Stansberry, K. B. (1996)  Qauntitative sensory testing (QST) (A Reply). Muscle & Nerve, 19: 403-404.  Pubmed Link

4.             Vinik, A. I., Stansberry, K. B. (1996)  Quantitative measurement of cutaneous perception in diabetic neuropathy (A Reply). Muscle & Nerve 19: 404-406.  Pubmed Link

5.             Vinik, A. I., Stansberry, K. B. (1996)  Quantitative measurement of cutaneous perception in diabetic neuropathy (A Reply). Muscle & Nerve, 19, 407.  Pubmed Link

6.             Stansberry, K. B., Shapiro, S. A., Hill, M. A., McNitt, P. M., Meyer, M. D., & Vinik, A. I. (1996)  Impaired peripheral vasomotion in diabetes. Diabetes Care 19(7): 715-721.  Pubmed Link

7.             Levitt, N. S., Stansberry, K. B., Wynchanck, S., Vinik, A. I. (1996)  Natural progression of autonomic neuropathy and autonomic function tests in a cohort of IDDM.  Diabetes Care 19(7): 751-754.  Pubmed Link

8.             Stansberry, K. B., Hill, M. A, Shapiro, S. A., McNitt, P. M., Bhatt, B. A., & Vinik, A. I. (1997)  Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect.  Diabetes Care 20:1711-1716.  Pubmed Link

9.             Shapiro, S. A., Stansberry, K. B., Hill, M. A., Meyer, M. D., McNitt, P. M., Bhatt, B. A., & Vinik, M. D. (1998)  Normal blood flow response and vasomotion in the diabetic Charcot foot. Journal of Diabetes and its Complications 12:147-153.  Pubmed Link

10.         Milicevic, Z., Newlon, P. C., Pittenger, G. L., Stansberry, K. B., Vinik, A. I. (1997)  Anti-ganglioside GM1 antibody and distal symmetric “diabetic polyneuropathy” with dominant motor features. Diabetologia 40: 1364-1365.  Pubmed Link

11.         Stansberry, K. B., Peppard, H. R., Babyak, L. M., Popp, G., McNitt, P. M., & Vinik, A. I. (1999)  Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: A new model for the pathogenesis of microvascular dysfunction. Diabetes Care 22:1549-1554.  Pubmed Link  Full Text (pdf)

12.         Knezevic-Cuca, J., Stansberry, K. B., Johnston, G., Zhang, J., Keller, E. T., Vinik, A.I., Pittenger, G. L. (2000)  Neurotrophic role of interleukin-6 and soluble interluekin-6 receptors in N1E-115 neuroblastoma cells. Journal of Neuroimmunology 102:8-16.  Pubmed Link

13.         Resnick H.E., Stansberry K.B., Harris T.B., Tirivedi M., Smith K., Morgan P., Vinik A.I. (2002)  Diabetes, peripheral neuropathy, and old age disability.  Muscle & Nerve 25:43-50.  Pubmed Link

14.         Colberg SR, Stansberry KB, McNitt PM, Vinik AI. (2002)  Chronic exercise is associated with enhanced cutaneous blood flow in type 2 diabetes. Journal of Diabetes Complications 16(2):139-45.  Pubmed Link

15.         Vinik AI, Stansberry KB, Barlow PM. (2003)  Rosiglitazone treatment increases nitric oxide production in human peripheral skin: a controlled clinical trial in patients with type 2 diabetes mellitus.  J Diabetes Complications. 17:279-85.  Pubmed Link

IX. Chapters in Books

1.         Vinik, A. I., Newlon, P. G., Milicevic, Z., McNitt, P., and Stansberry, K. B.  (1996).  Diabetic neuropathies:  An overview of clinical aspects.  In D. LeRoith, S. I. Taylor, and J. M. Olefsky (Eds.):  Diabetes mellitus:  A fundamental and clinical text.  (pp. 737-751).  Philadelphia:  Lippincott-Raven. 

2.         Vinik, A. I., Erbas, T., Stansberry, K. B., Pittenger, G. L. (2001)  Small fiber neuropathy and neurovascular disturbances in diabetes mellitus.  In K. Voigt, H. Schatz (Eds.-in-Chief), S. A. Raptis and G. D. Dimitriadis (Volume Eds.): Diabetes mellitus at the dawn of the new millennium:  Advances in pathogenesis and treatment.  Experimental and Clinical Endocrinology and Diabetes 109:S451-S473. 

 

X. Abstracts and Scientific Presentations, Posters

(underlined author gave presentation)

1.         Stansberry, K. B., Coates, G. D., Cunningham, S., Coffman, L., & Lichty, W. L. (1991).  Serial and parallel processing from setsize effects in an item-recognition task (Report No. 537).  Washington, DC: American Psychological Society.

2.         Suwanwalaikorn, S., Stansberry, K. B., McNitt, P. M., and Vinik, A. I. (1992).  Quantitative measurement of cutaneous perception in diabetic neuropathy (Program No. 111). San Antonio, TX:  American Diabetes Association Scientific Sessions.  Abstract published in Diabetes, 41S.

3.         Pavlic-Renar, I., Stansberry, K. B., Abelson, J. L., and Vinik, A. I. (1993). Plasma neurokinin A in flushing syndrome (Program No. 744).  Las Vegas, NV: The Endocrine Society.

4.         Levitt, N. S., Stansberry, K. B., Wynchanck, S., and Vinik, A. I. (1993).  The natural history of autonomic neuropathy in a cohort of IDDM (Program No. 311).  Las Vegas, NV: American Diabetes Association National Scientific and Professional Sessions.  Diabetes 42S.  (Abstract)

5.         Stansberry, K. B., Hill, M., McNitt, P. M., Bhatt, B. A., and Vinik, A. I. (1994).  Skin blood flow reactivity and neuropathy (Program No. 334).  New Orleans, LA: American Diabetes Association National Scientific and Professional Sessions.  Diabetes 43(S1): 107A.  (Abstract)

6.         Stansberry, K. B., Hill, M., McNitt, P. M., Bhatt, B. A., and Vinik, A. I. (1994).  Skin blood flow reactivity and neuropathy (Program No. 13).  Bethesda, MD: National Institutes of Health and NIDDK; Mid-Atlantic Diabetes Research Symposium.

7.         Stansberry, K. B., Hill, M., McNitt, P. M., Meyer, M., Vinik, A. I. (1995).  Peripheral vasomotion in diabetes (Program No. 630).  Atlanta, GA: American Diabetes Association Scientific Sessions.  in Diabetes 44(S1): 172A.  (Abstract)

8.         Vinik, A. I., Stansberry, K. B., McNitt, P. M., Anzalone, D., Wilson, A. (1995).  Circadian blood pressure (CBP) is a determinant of microalbuminuria in IDDM (Program No. 401).  Atlanta, GA: American Diabetes Association Scientific Sessions. Diabetes 44(S1): 108A.  (Abstract)

9.         Stansberry, K. B., Hill, M., McNitt, P. M., Meyer, M., Vinik, A. I. (1995).  Peripheral vasomotion in diabetes (Program No. 14).  Bethesda, MD: National Institutes of Health and NIDDK; Mid-Atlantic Diabetes Research Symposium.

10.     Stansberry, K. B., Vinik, A. I., Newlon, P. G., McNitt, P. M., Hari, K. (1996)  Which psychophysical algorithm is appropriate for measuring skin sensation in diabetic neuropathy?  (Program No. 769).  San Francisco, CA:  American Diabetes Association Scientific Sessions.  Diabetes 45(S2): 209A.  (Abstract)

11.     Stansberry, K. B., Vinik, A. I., Newlon, P. G., Hanling, D. J., McNitt, P. M., Hari, K. (1996)  Diabetic sensory neuropathy is associated with reduced IGF-1 and BP-3, but normal levels of inflammatory cytokines in serum.  Diabetes 45(S2): 277A.  (Abstract)

12.     Milicevic, Z., Pittenger, G. L., Stansberry, K. B., Vinik, A. I. (1997)  Raised anti-ganglioside GM1 antibody (GM1 Ab) titers in a subset of patient with distal symmetric polyneuropathy (DSPN).  Boston, MA: American Diabetes Association Scientific Sessions.  Diabetes, 46:S1, 125A.  (Abstract)

13.     Stansberry, K. B., Neumann, D. A., McNitt, P. M., Thornton, K. R., Vinik, A. I. (1997)  Peripheral microvascular response to hydrostatic pressure is spared in diabetic nephropathy.  Diabetes 46(S1): 304A.  (Abstract)

14.     Stansberry, K. B., Peppard, H. R., Babyak, L. M., McNitt, P. M., Popp, G, Vinik, A. I. (1998)  Heat-induced vasodilation, a new sensitive, specific test of C-fiber dysfunction in diabetes.  Diabetes 47(S1): A377.  (Abstract)

15.     Bhatt, B. A., Stansberry, K. B., McNitt, P. M., Atit, R., Vinik, A. I. (1998)  The Effects of adrenergic blockade on skin blood flow and pain processing in painful diabetic neuropathy.  Diabetes 47(S1): A376.  (Abstract)

16.     Stansberry, K. B., Nasr, N., McNitt, P. M., Vinik, A. I. (1998)  Insensitivity of the 10 gram monofilament testing compared to the quantitative monofilaments and other somatosensory tests in diabetic neuropathy.  Diabetes 47(S1): A84.  (Abstract)

17.     Milicevic, Z., Liuzzi, F. J., Pittenger, G. L., Stansberry, K. B., Carson, K. A., Softic, D., Vinik, A. I. (1998)  Morphometric and immunopathologic characteristics of sural nerve from patients with distal symmetric diabetic polyneuropathy.  Diabetes 47(S1): A133.  (Abstract)

18.     Stansberry, K. B., Peppard, H. R., Cucchi, S., McNitt, P. M., Vinik, A. I. (1999)  Nociceptor vasodilation is exaggerated in essential hypertension but paradoxically impaired in the hypertension of type 2 diabetes.  Diabetes 48(S1): A372.  (Abstract)

19.     Stansberry, K. B., Moss, Q. E., Peppard, H. R., McNitt, P. M., Vinik, A. I. (1999)  Intravenous bisphosphonate rapidly reverses the paradoxical increase in blood flow to the foot in Charcot neuroarthropathy.  Presented at American Diabetes Association 59th Scientific Sessions, San Diego, CA, Diabetes 48(S1): A92.  (Abstract)

20.     Pittenger, G. L., Burcus, N.I., Stansberry, K. B., Vinik, A. I. (1999)  Neuroblastoma cell toxicity indicates serum factors toxic to small, unmyelinated nerve fibers in diabetic and non-diabetic neuropathies. Diabetes 48(S1): A384.  (Abstract)

21.      Grant, W. P., Sullivan, R., Sonenshine, D. E., Stansberry, K. B., Moss, Q. E., Peppard, H. R., McNitt, P. M., Vinik, A. I. (1999)  Treatment of Charcot neuroarthropathy with Achilles tendon lengthening.  Diabetes 48(S1): A401.  (Abstract)

22.     Stansberry KB, Scanelli JA, Peppard HR, McNitt PM and Vinik AI (2000).  Direct in vivo measurement of nitric oxide in human skin: Differing involvement of nitric oxide in ischemia reperfusion and neurogenic vasodilation. Diabetes 49(Supplement 1):A197 (Abstract).

23.     Stansberry KB, Resnick HE, Tiriveedi M, Tesoriere PJ, Morgan PJ and Vinik AI (2000).  Diabetic peripheral neuropathy impairs balance beyond the effects of aging and diabetes alone. Diabetes 49(Supplement 1):A167 (Abstract).

24.     Vinik EJ, Stansberry KB, Zarrabi L, Witherspoon CG, McNitt PM and Vinik AI (2000).  Development of a sensitive, specific quality of life inventory for peripheral neuropathy. Diabetes 49(Supplement 1):A189 (Abstract).

25.     Stansberry KB, Scanelli JA, Pierce KK, McNitt PM and Vinik AI (2001).  Skin perfusion responses to warming are dependent on nitric oxide synthase, intact neurons, and level of warming.  Diabetes 50(Supplement 1): (Abstract)

26.     Vinik EJ, Stansberry KB, Ruck SM, Vinik AI (2003).  Evaluation of quality of life in patients with neuropathy using the Norfolk Quality of Life (QOL) tool.  Presented at the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Semi-Annual Sessions, Alexandria, Virginia.

27.     Vinik EJ, Stansberry KB, Doviak MJ, Ruck SM, Vinik AI (2003).  Norfolk quality of life (QOL) tool: Scoring and reproducibility in healthy people, diabetic controls and patients with neuropathy.  Diabetes 52(Supplement 1): (Abstract 849-P) 

28.     Vinik EJ, Stansberry KB, Vinik AI (2003)  Neuropathy quality of life tool (Norfolk QOL-DN) in a large clinical trial: Comparison with symptom scores (NSS), nerve impairment (NISS), quantitative sensory (QST), autonomic (QAFT) tests and electrophysiology.  Diabetes 52(Supplement 1): (Abstract 31-LB)

29.     Parson HK, Stansberry KB, Jarecki JL, Vinik AI (2003)  A microvascular defect mediated by CGRP is acutely reduced in newly diagnosed type 2 diabetes and partially compensated later in the course of type 2 diabetes.  Diabetes 52(Supplement 1): (Abstract 1035-P)

30.     Mason ME, Ullal J, Stansberry KB, Vinik AI (2003)  Heating stimulates nitric oxide production and a transient increase in cGMP in peripheral skin in type 2 diabetes.  Endocrine Society 85th Annual Meeting, Philadelphia PA.

31.     Stansberry KB, Vinik AI (2003)  Pioglitazone treatment improves nitrosative stress and microvascular function through lipid and hematologic metabolism.  18th International Diabetes Federation Congress, Paris, France.

XI. Scientific Presentations, Platform Presentations

      (underlined author gave presentation)

1.         Pittenger, G. L., Stansberry, K. B., Vinik, A. I. (1997).  Failure of neurotrophic support as a mechanism for pathogenesis of diabetic neuropathy.  Cambridge, England:  Peripheral Nerve Society.

2.         Stansberry, K. B., Moss, Q. E., Peppard, H. R., McNitt, P. M., Vinik, A. I. (1999).  Intravenous bisphosphonate rapidly reverses the paradoxical increase in blood flow to the foot in Charcot neuroarthropathy.  Presented as a poster discussion at American Diabetes Association 59th Scientific Sessions, San Diego, CA, 1999.

3.         Stansberry KB, Scanelli JA, McNitt PM and Vinik AI (2000).  Nitric oxide production mediates neurogenic vasodilation in human skin but is not impaired in type 2 diabetes. Diabetes 49(Supplement 1):A33 (Abstract).  Presented as a podium presentation at American Diabetes Association 60th Scientific Sessions, San Antonio, TX, June 2000.

4.         Stansberry KB, Scanelli JA, Peppard HR, McNitt PM and Vinik AI (2000).  Direct in vivo measurement of nitric oxide in human skin: Differing involvement of nitric oxide in ischemia reperfusion and neurogenic vasodilation. Diabetes 49(Supplement 1):A197 (Abstract).  Presented as a poster discussion at American Diabetes Association 60th Scientific Sessions, San Antonio, TX, June 2000.

5.         Stansberry KB and Vinik AI (2001)  Nitric oxide sensitivity is impaired in impaired glucose tolerance (IGT) and first order relatives of patients with type 2 diabetes.  Diabetes 50(Supplement 1):      (Abstract).  Presented as a podium presentation at the American Diabetes Association 61st Scientific Sessions

6.         Vinik AI, McNitt PM and Stansberry KB (2001)  Nitric oxide sensitivity is impaired in obesity and type 2 diabetes.  Diabetes 50(Supplement 1):  (Abstract).  Presented as a poster discussion session at the American Diabetes Association 61st Scientific Sessions

7.         Vinik AI, Stansberry KB, McNitt PM (2002)  Rosiglitazone treatment Increases nitric oxide production in human peripheral skin: A controlled clinical trial.  Diabetes 51(Supplement 2):A82  (Abstract 333).  Presented at the American Diabetes Association 62nd Scientific Sessions, San Francisco, CA

8.         Vinik AI, Pittenger GL, Anderson SA, Stansberry KB, McNear E, Barlow PM (2003). Topiramate improves C-fiber neuropath and features of the dysmetabolic syndrome in type 2 diabetes.  Diabetes 52(Supplement 1): (Abstract 66-OR).  Presented at the American Diabetes Association 63rd Scientific Sessions, New Orleans, LA

9.         Vinik AI, Mehrabyan AC, Stansberry KB, Pittenger GL (2003)  Skin biopsy in diabetes and the metabolic syndrome:  External validation by comparison with other neurologic tests and metabolic parameters.  (Abstract no. 88) Presented at the 13th Annual Meeting of the Diabetic Neuropathy Study Group of the EASD (NEURODIAB XIII), Saint Malo, France